Schedule 13D ownership disclosure

INHIBIKASE THERAPEUTICS INC

Security class unavailable · CUSIP: 45719W106

Event date: 2022-01-10

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,517,000
Percent of class
6.0300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001513162-22-000005
Form type
SC 13D
Filer
FiveT Investment Management Ltd
CIK
CIK 1846823
Filed
Jan 11, 2022
Reporting period
Jan 10, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub